Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Lesions in Native Coronary Arteries”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableStudy completedNCT00614848
What this trial is testing

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

Who this might be right for
Coronary Artery DiseaseArterial Occlusive DiseasesCoronary Disease+6 more
Medtronic Vascular 1,200
Not applicableStudy completedNCT00217256
What this trial is testing

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 436
Not applicableStudy completedNCT01425281
What this trial is testing

ABSORB II Randomized Controlled Trial

Who this might be right for
Coronary Artery Disease
Abbott Medical Devices 501
Large-scale testing (Phase 3)Study completedNCT00232765
What this trial is testing

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 1,058
Not applicableStudy completedNCT02480348
What this trial is testing

Medtronic RevElution Trial

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 109
Not applicableStudy completedNCT01583608
What this trial is testing

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Who this might be right for
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial Ischemia+7 more
Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. 183
Post-approval studies (Phase 4)Study completedNCT04483791
What this trial is testing

DynamX Bioadaptor Hong Kong Registry

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 50
Not applicableStudy completedNCT01761578
What this trial is testing

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Who this might be right for
Coronary Artery Disease
Arterial Remodeling Technologies 30
Not applicableUnknownNCT01960504
What this trial is testing

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)

Who this might be right for
Coronary Artery DiseaseCoronary Artery Stenosis
Biotronik AG 123
Large-scale testing (Phase 3)Study completedNCT00322569
What this trial is testing

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Who this might be right for
Coronary Disease
Cordis US Corp. 246
Not applicableStudy completedNCT00792753
What this trial is testing

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 360
Not applicableStudy completedNCT02716220
What this trial is testing

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)

Who this might be right for
Coronary Artery DiseaseCoronary Artery Stenosis
Biotronik AG 61
Not applicableEnded earlyNCT04025788
What this trial is testing

BIOSOLVE-IV Magmaris Swiss Satellite Registry

Who this might be right for
Coronary Artery Disease
University Hospital, Geneva 10
Testing effectiveness (Phase 2)Study completedNCT00248066
What this trial is testing

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

Who this might be right for
Coronary Artery DiseaseCoronary Restenosis
Sarepta Therapeutics, Inc. 50
Not applicableStudy completedNCT00726453
What this trial is testing

The Medtronic RESOLUTE US Clinical Trial

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 1,516
Large-scale testing (Phase 3)Study completedNCT00307047
What this trial is testing

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Who this might be right for
Coronary Artery Disease
Abbott Medical Devices 3,687
Not applicableStudy completedNCT01923740
What this trial is testing

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)

Who this might be right for
Coronary Artery DiseaseCoronary Artery StenosisCoronary Disease+1 more
Abbott Medical Devices 480
Not applicableStudy completedNCT02086045
What this trial is testing

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 126
Testing effectiveness (Phase 2)Study completedNCT01294748
What this trial is testing

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Micell Technologies 184
Not applicableStudy completedNCT00927940
What this trial is testing

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

Who this might be right for
Arterial Occlusive DiseasesMyocardial IschemiaCardiovascular Diseases+1 more
Medtronic Vascular 100
Load More Results